ArticleBMC urology2026
Uptake of prostate biopsy and its associated factors among patients previously confirmed to have elevated prostate-specific antigen levels at Kyabirwa surgical center, Jinja city: a cross-sectional study.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess prostate biopsy uptake and its associated factors among patients previously found to have elevated Prostate-Specific Antigen results at the Kyabirwa Surgical Center (KSC).
methodAn analytical cross-sectional design was employed to study 52 male patients with elevated PSA levels (> 10 ng/mL) at the Kyabirwa Surgical Center. They were consecutively sampled, located in their areas of residence, and engaged in structured interviews. Data were collected and analyzed descriptively using SPSS version 26, with a log-binomial model for relationship analysis.
resultsThe proportion of patients with elevated PSA levels at the KSC who underwent prostate biopsy was 55.8%, with most having their biopsies performed at the center (72.4%). Perceived good health status (aPR = 0.368¸95% CI = 0.155-0.877, p = 0.024) lowered the prevalence of uptake. However, educating patients about prostate health KSC (aPR = 2.150, 95% CI = 1.157-3.995, p = 0.015), the cost of a prostate biopsy (aPR = 2.647, 95% CI = 1.374-5.099, p = 0.004), the meaning of PSA results (aPR = 2.647, 95% CI = 1.374-5.099, p = 0.004), the importance of a biopsy, how it is performed (aPR = 2.078, 95% CI = 1.137-3.798, p = 0.016), and being followed up by healthcare workers at KSC to determine compliance with the instructions to perform a biopsy (aPR = 1.603, 95% CI = 1.074-2.394, p = 0.021) were associated with a higher prevalence of biopsy uptake.
conclusionOnly half of the patients who have elevated Prostate-Specific Antigen levels at the Kyabirwa Surgical Center and are advised to have a prostate biopsy done, go ahead and undergo biopsy. Only a few of them still have the biopsy done at other facilities, further emphasizing the fact that prostate cancer screening behavior is poor among men who are urged to undergo screening via biopsy by the KSC staff. The negative factors associated with prostate biopsy uptake are patient-related, while all positive factors associated with biopsy uptake are institutional and specifically related to post-test patient education.
Indexed as
Identifiers
42482195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.